SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced today that SK bioscience and Sanofi have initiated the submission process of an Investigational New Drug(IND) amendment to the U.S. Food and Drug Administration(FDA)
Hyundai Motor will shut down its local plant, which once drove the automaker’s strong sales in Russia, by the end of this year. Some local reports say that the Korean carmaker will sell the plant to a local company in Russia in the aftermath of the Russian-Ukrainian war.Hyundai Motor plans to close
The government is opening up industrial research and development (R&D) to foreign institutions to discover and develop key technologies in areas vulnerable to becoming weak links in South Korea’s flagship industry value chains, such as “technology critical for leapfrogging,” “next-generation growth-
The author is an analyst for NH Investment & Securities. He can be reached at pk.park@nhqv.com -- Ed.Lundbeck has announced to first target TED and MS with APB-A1. The phase II study for TED should begin in 3Q24. Showing confidence in the CD40L pipeline, the firm sees superiority to IGF-1R inhibitor
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company’s board of directors has decided to invest in the expansion of L HOUSE, a vaccine manufacturing plant of SK bioscience located in Andong, South Korea to ap
A race to host the 2030 World Expo is coming down to the wire. The Bureau International des Expositions (BIE) will hold a general assembly in Paris, France, on Nov. 28 (local time) to select the host country for the 2030 World Expo.Korea started its bid about one year later than its rivals such as S
The acquisition battle for South Korea’s largest shipping company HMM has narrowed to a competition between Dongwon Group and Harim Group.According to investment banking (IB) sources on Nov. 23, HMM’s bondholders, including Korea Development Bank (KDB), Korea Ocean Business Corporation, and the sell
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entered into a development licensing agreement with Hilleman Laboratories, a vaccines and biologics research and development organization committed to
Korea has only 0.5 percent of the world’s specialized AI talent. Out of 30 countries, Korea placed only 22nd in AI talent retention.The Federation of Korean Industries (FKI) released a report on AI Talent Acquisition Strategies and Implications for Korea, the United States and China on Nov. 20. The
Chong Kun Dang announced on Nov. 6 that it has entered into a technology export agreement with Novartis worth US$1.305 billion for its new drug candidate CKD-510.Under the agreement, Novartis obtains exclusive rights outside of South Korea for the development and commercialization of CKD-510, a low-
The ongoing merger process between Korean Air and Asiana Airlines, which has persisted for three years, has crossed a significant threshold. Korean Air’s proposal to divest Asiana Airlines’ cargo division has been approved by the board of Asiana Airlines, a strategic move to meet the requirements se
As Samsung marks the first anniversary of Chairman Lee Jae-yong’s inauguration, the company is ramping up efforts to bolster the prominence of its board. On Oct. 26, Samsung SDI and Samsung SDS held board meetings where they decided to introduce a “Senior Outside Director” system.The Senior Outside
The ongoing takeover battle for HMM, which had been a three-way competition between Harim Group, LX Group, and Dongwon Group, could face another twist. There’s speculation that POSCO might enter the acquisition fray, intensifying the competition among potential acquirers. Amid this, the prospective
The author is an analyst for NH Investment & Securities. He can be reached at seungyeon.han@nhqv.com -- Ed.In November, J&J is expected to release phase II data for nipocalimab in the treatment of rheumatology. The firm has already released some of the data from its abstract for the ACR conference.
MBK Partners’ Chairman Kim Byung-ju’s best-selling novel “Offerings” is set to be adapted into a film.Hollywood’s Anonymous Content will co-produce the movie with Anthology Studios, established by Director Kim Ji-woon and Actor Song Kang-ho.According to the entertainment industry’s esteemed media ou
AprilBio revealed on Oct. 5 that they have obtained a U.S. patent for their candidate drug for autoimmune disease treatment, known as “APB-A1” (development code name, partner company Lundbeck code name Lu-AG22515).In October 2021, APB-A1 was exported to Lundbeck, a multinational pharmaceutical compa
GC Biopharma Corp. announced on Oct. 5 that their therapeutic candidate for Thrombotic Thrombocytopenic Purpura (TTP), “GC1126A,” has received a Rare Drug Designation from the U.S. Food and Drug Administration (FDA).As a result of this designation, GC1126A will benefit from tax deductions on researc
Daewoong Pharmaceutical is rapidly securing its position in the market by consecutively acquiring patents related to the treatment of autoimmune diseases. The company announced on Oct. 4 that it has registered three patents related to autoimmune disease treatments over the past six months.To date, D
SK on has secured the top position in Fortune’s “Change the World” list, an accolade that recognizes the world’s most innovative companies. This achievement marks the highest-ever ranking for a global battery manufacturer.On Sept. 27 (local time), Fortune unveiled its list of “2023 World-changing In
The author is an analyst for NH Investment & Securities. He can be reached at seungyeon.han@nhqv.com -- Ed.On Sep 26, the share price of HanAll Biopharma partner Immunovant jumped by over 97% on surprise interim data from the IMVT-1402 phase I trial. Encouraging results were reported in terms of bot